What It Is SaliVance™ is a patent-pending, non-drug, and non-electronic oral wellness accessory designed to alleviate the daily discomfort of dry mouth. It is a silicone appliance featuring a stabilizing stem and dual flexible arms that ergonomically contour to the sublingual and buccal areas of the lower jaw. Why It Matters Millions of consumers suffer from oral dryness due to aging, lifestyle, or medication side effects. Current solutions (gels, sprays, and rinses) are palliatives that provide only transient relief and often contain chemicals or artificial sweeteners. SaliVance™ introduces a new category: Mechanical Oral Hydration. It offers a sustainable, chemical-free, and cost-effective alternative that empowers users to maintain their own oral comfort without recurring consumable costs. How It Works SaliVance™ utilizes "mechano-therapy." The specialized texture of the silicone surface, combined with natural tongue movement against the device’s flexible arms, provides continuous tactile stimulation to the oral mucosa. This physical interaction leverages the body’s physiological response to promote a natural sensation of moisture and freshness. It is designed for high compliance, requiring only a few minutes of daily use to support a lasting feeling of comfort. Proof to Date Developed by Saliwell Ltd., a leader in salivary neurostimulation, SaliVance™ is the result of extensive clinical expertise in oral health. The product is currently "market-ready," featuring sleek, retail-ready blister packaging designed for immediate placement in global pharmacy and drugstore aisles. Initial feedback confirms high user preference for its drug-free, non-invasive nature compared to traditional topical agents. Next Steps Our goal is to transition SaliVance™ from a specialized wellness tool to a global mass-market essential. We are prepared to provide technical dossiers and physical samples for evaluation. Website: https://saliwell.com/salivance/
Saliwell Ltd. is a medical device company that develops non-pharmacological, high-tech solutions for xerostomia, commonly known as dry mouth. The company's core product, SaliPen, is an FDA-cleared, removable intraoral device that uses gentle electrostimulation to activate salivary glands and promote natural saliva production. By delivering targeted electrical impulses to the lingual nerve, the device provides a drug-free alternative to traditional pharmacological treatments, which often carry undesirable side effects. The technology is designed to be used for short durations throughout the day to help patients manage symptoms, improve oral comfort, and facilitate speaking and swallowing.
This approach matters to patients suffering from chronic dry mouth, including those with conditions like Sjögren’s syndrome or those experiencing salivary gland dysfunction due to medication use. Saliwell’s solution addresses the significant daily challenges and health risks associated with insufficient saliva, such as increased dental decay and oral discomfort. The efficacy of the company's electrostimulation technology has been supported by published clinical research, including randomized sham-controlled studies demonstrating meaningful improvements in salivary function and patient-reported symptoms. Led by founders Dr. Andy Wolff, a specialist in oral medicine, and Ben Z. Beiski, an engineer, Saliwell continues to advance its technology through ongoing research and development to improve the quality of life for xerostomia patients worldwide.